NCT06699810View on ClinicalTrials.gov

Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity

PHASE4RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 23, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Ketosis Prone Diabetes
Interventions
DEVICE

Continuous Glucose Monitoring

After insulin discontinuation participants continue wearing their CGMs, for a total of 3 months.

DRUG

Insulin

Participants will receive standard-of-care insulin treatment. Insulin dosing will be adjusted based on CGM glucose readings.

Trial Locations (2)

30303

RECRUITING

Grady Health System, Atlanta

30308

RECRUITING

Emory University Hospital Midtown, Atlanta

All Listed Sponsors
lead

Emory University

OTHER